KROS SEC Form 4 filings

Keros Therapeutics, Inc. Latest Insider Trading Activity

The most recent employee insider trading activity for Keros Therapeutics, Inc. was on June 15, 2026, when Bienaime Jean Jacques (Director) reported a purchase of 1,000 shares at $10.19 per share. For the past 1,555 days, KROS has had 10 total insider transactions represented in the displayed records. This page shows up to the 10 most recent SEC Form 4 filing records on a 6-hour delay. Sign up for real-time updates and access to 20 years of historic insider trading data.

Insider Trading For KROS Charted on Daily Candles. Scroll left or zoom out to load earlier candles (up to 2 years).

▲ Insider buy ▼ Insider sale
Loading daily price history…
Charting by TradingView Lightweight Charts
Ticker Filing Date Transaction Date Company Insider Title Transaction Trade Count Shares Avg. Price Total Value Position Size Change SEC Filing
10b5-1: Scheduled Form 4 Transaction KROS 2026-06-17 2026-06-15 Keros Therapeutics, Inc. Bienaime Jean Jacques Director Buy 1 1,000 $10.19 $10,190.00 5.68% View Filing
10b5-1: Scheduled Form 4 Transaction KROS 2026-06-15 2026-06-11 Keros Therapeutics, Inc. Newton Charles W. Director Sell 1 550 $10.04 $5,522.00 4.16% View Filing
10b5-1: Scheduled Form 4 Transaction KROS 2026-06-08 2026-06-04 Keros Therapeutics, Inc. Knowles Julius Director Sell 1 2,625 $10.73 $28,166.25 19.33% View Filing
10b5-1: Scheduled Form 4 Transaction KROS 2026-06-08 2026-06-04 Keros Therapeutics, Inc. Farzan Nima Director Sell 1 2,625 $10.73 $28,166.25 21.18% View Filing
10b5-1: Scheduled Form 4 Transaction KROS 2026-06-05 2026-06-04 Keros Therapeutics, Inc. Seth Alpna Director Sell 1 2,625 $10.72 $28,140.00 21.18% View Filing
10b5-1: Scheduled Form 4 Transaction KROS 2026-05-19 2026-05-15 Keros Therapeutics, Inc. Bienaime Jean Jacques Director Buy 1 1,000 $10.58 $10,580.00 10.58% View Filing
10b5-1: Scheduled Form 4 Transaction KROS 2026-04-17 2026-04-15 Keros Therapeutics, Inc. Bienaime Jean Jacques Director Buy 1 1,000 $11.70 $11,700.00 11.83% View Filing
Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KROS 2026-02-20 2026-02-19 Keros Therapeutics, Inc. Seehra Jasbir CHIEF EXECUTIVE OFFICER Sell 1 7,015 $16.17 $113,432.55 1.79% View Filing
Tax liability coverage transfers: shares are often sold to offset the tax liability from shares vesting KROS 2026-02-20 2026-02-18 Keros Therapeutics, Inc. Lerner Lorena Raquel Chief Science Officer Sell 1 3,873 $16.35 $63,323.55 11.07% View Filing
Explained M/S: sale activity tied to share conversions or derivative-related share movements. KROS 2022-07-19 2022-07-15 Keros Therapeutics, Inc. Lachey Jennifer Chief Scientific Officer Sell 1 46,034 $30.00 $1,381,020.00 32.62% View Filing

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.89 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.